John C Waterton


Affiliation: University of Manchester
Country: UK


  1. Skeoch S, Weatherley N, Swift A, Oldroyd A, Johns C, Hayton C, et al. Drug-Induced Interstitial Lung Disease: A Systematic Review. J Clin Med. 2018;7: pubmed publisher
    ..Overall high-quality evidence in DIILD is lacking, and the current review will inform larger prospective studies to investigate the diagnosis and management of DIILD. ..
  2. Waterton J, Ho M, Nordenmark L, Jenkins M, Dicarlo J, Guillard G, et al. Repeatability and response to therapy of dynamic contrast-enhanced magnetic resonance imaging biomarkers in rheumatoid arthritis in a large multicentre trial setting. Eur Radiol. 2017;27:3662-3668 pubmed publisher
    ..DCE-MRI K trans showed fostamatinib inferior to adalimumab after 6 weeks. • K trans repeatability coefficient of variation was 30% multicentre. ..
  3. Little R, Barjat H, Hare J, Jenner M, Watson Y, Cheung S, et al. Evaluation of dynamic contrast-enhanced MRI biomarkers for stratified cancer medicine: How do permeability and perfusion vary between human tumours?. Magn Reson Imaging. 2018;46:98-105 pubmed publisher
    ..Instead, Ktrans is an idiopathic parameter, and, where permeability is important, Ktrans should be measured in each tumour to personalise that treatment. ..